scout
|Videos|October 24, 2017

Dr. Armstrong Discusses AR-V7 Testing in Prostate Cancer

Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses AR-V7 testing in prostate cancer.

Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses AR-V7 testing in prostate cancer.

Currently, there are 2 lead candidates for the AR-V7 test—the Epic Sciences AR-V7 Test from Genomic Health, and a Johns Hopkins assay that is based on RNA.

Neither of these studies are FDA approved, but both are undergoing prospective validation.

Newsletter

Stay up to date on the most recent and practice-changing oncology data


Latest CME